Gene therapy for neurological disorders: challenges and recent advancements-Reference-Cited by-同舟云学术

Gene therapy for neurological disorders: challenges and recent advancements

Published:2019-07-11 Issue:2 Volume:28 Page:111-128
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Pena Stefanie A.¹,Iyengar Rahul¹,Eshraghi Rebecca S.¹,Bencie Nicole¹,Mittal Jeenu¹,Aljohani Abdulrahman¹,Mittal Rahul¹^ORCID,Eshraghi Adrien A.¹²³^ORCID

Affiliation:

1. Department of Otolaryngology, Hearing Research Laboratory, University of Miami Miller School of Medicine, Miami, FL, USA;

2. Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, USA;

3. Department of Biomedical Engineering, University of Miami Miller School of Medicine, Miami, FL, USA

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2019.1630415

Reference160 articles.

1. The State of US Health, 1990-2010

2. The burden of neurological disease in the United States: A summary report and call to action

3. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

4. Monetary Costs of Dementia in the United States

5. US population aging and demand for inpatient services

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. Engineered chitosan-derived nanocarrier for efficient siRNA delivery to peripheral and central neurons;2024-09-10

3. Macromolecular Polymer Based Complexes: A Diverse Strategy for the Delivery of Nucleotides;Protein & Peptide Letters;2024-08-22

4. Progress in Research on the Role of the Thioredoxin System in Chemical Nerve Injury;Toxics;2024-07-15

5. Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders;Neurotherapeutics;2024-07